WO2023131690 - SUBSTITUTED HETEROCYCLES AS HSET INHIBITORS
National phase entry:
Publication Number
WO/2023/131690
Publication Date
13.07.2023
International Application No.
PCT/EP2023/050255
International Filing Date
09.01.2023
Title **
[English]
SUBSTITUTED HETEROCYCLES AS HSET INHIBITORS
[French]
HÉTÉROCYCLES SUBSTITUÉS EN TANT QU'INHIBITEURS DE HSET
Applicants **
MERCK PATENT GMBH
THE INSTITUTE OF CANCER RESEARCH
CANCER RESEARCH HORIZONS
Inventors
BUCHSTALLER, Hans-Peter
KUHN, Daniel
COLLINS, Ian
MATTHEWS, Thomas
LANZ, Jan
CALDWELL, John
COLOMBANO, Giampiero
Priority Data
22150667.8
10.01.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5090 | |
| EPO | Filing, Examination, Granting | 20955 | |
| Japan | Filing, Examination, Granting | 2338 | |
| South Korea | Filing, Examination, Granting | 2448 | |
| USA | Filing, Examination, Granting | 10640 |
Total:
41,471
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The invention relates to substituted heterocycles of the general formula (I), wherein W is thiazole, thiophene, pyrazole, imidazole or isoxazole, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compounds.[French]
L'invention concerne des hétérocycles substitués de formule générale (I), dans laquelle W est thiazole, thiophène, pyrazole, imidazole ou isoxazole, et l'utilisation des composés de la présente invention pour le traitement et/ou la prévention de maladies et de troubles d'hyperprolifération chez des mammifères, en particulier des êtres humains, et des compositions pharmaceutiques contenant de tels composés.